These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8036138)

  • 1. Thrombotic complications of polycythemia. The venous and arterial risk factors.
    Fiessinger JN
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):179-81. PubMed ID: 8036138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective analysis of thrombotic events in the European collaboration study on low-dose aspirin in polycythemia (ECLAP).
    Finazzi G;
    Pathol Biol (Paris); 2004 Jun; 52(5):285-8. PubMed ID: 15217715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of arterial thrombotic events in inflammatory bowel disease.
    Ha C; Magowan S; Accortt NA; Chen J; Stone CD
    Am J Gastroenterol; 2009 Jun; 104(6):1445-51. PubMed ID: 19491858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycythemia vera--a case report and discussion on pathogenic mechanisms of increased thrombosis.
    Gumina RJ; Foley DA; Tefferi A; Rooke TW; Shields RC
    Angiology; 2002; 53(5):587-91. PubMed ID: 12365868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial stenosis and atherothrombotic events in polycythemia vera and essential thrombocythemia.
    Cucuianu A; Stoia M; Farcaş A; Dima D; Zdrenghea M; Paţiu M; Olinic D; Petrov L
    Rom J Intern Med; 2006; 44(4):397-406. PubMed ID: 18386616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention.
    Landolfi R; Cipriani MC; Novarese L
    Best Pract Res Clin Haematol; 2006; 19(3):617-33. PubMed ID: 16781491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predisposing factors for thrombosis].
    Boneu B
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):187-90. PubMed ID: 8337121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic polyglobulia in the adult and vascular injuries].
    Di Lollo F; Di Lollo S
    Recenti Prog Med; 1985 Mar; 76(3):135-8. PubMed ID: 4012016
    [No Abstract]   [Full Text] [Related]  

  • 10. Laboratory investigations and prediction of thrombotic risk in polycythemia vera.
    Boneu B
    Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):183-5. PubMed ID: 8036139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercoagulable states as an evolving risk for spontaneous venous and arterial thrombosis.
    Levy PJ; Gonzalez FM; Rush DS; Haynes JL
    J Am Coll Surg; 1994 Mar; 178(3):266-70. PubMed ID: 8149019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature.
    Marie I; Maurey G; Hervé F; Hellot MF; Levesque H
    Br J Dermatol; 2006 Oct; 155(4):714-21. PubMed ID: 16965420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peripheral arterial occlusive disease and acute deep venous thrombosis--when and how to treat?].
    Heidrich H
    Verh Dtsch Ges Inn Med; 1990; 96():112-7. PubMed ID: 2092429
    [No Abstract]   [Full Text] [Related]  

  • 14. [Venous thrombosis of the legs and cancer. Evaluation of risk factors of venous thrombosis in the medical environment].
    Giauffret F; Pottier P; Pistorius MA; Planchon B
    J Mal Vasc; 1997 Oct; 22(4):234-8. PubMed ID: 9411008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
    Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vascular complications of essential thrombocythemia].
    Bellucci S
    Bull Acad Natl Med; 2007 Mar; 191(3):519-30; discussion 530-3. PubMed ID: 18072651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What vascular events suggest a myeloproliferative disorder?].
    Hachulla E; Rose C; Trillot N; Caulier-Leleu MT; Pasturel-Michon U
    J Mal Vasc; 2000 Dec; 25(5):382-387. PubMed ID: 11148402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia.
    Ann Intern Med; 1995 Nov; 123(9):656-64. PubMed ID: 7574220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral anticoagulants as secondary prophylaxis of thrombosis in patients with polycythemia vera: a retrospective analysis of 15 patients.
    Bachleitner-Hofmann T; Grumbeck E; Gisslinger H
    Thromb Res; 2003; 112(4):229-32. PubMed ID: 14987916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.